FLRT2
Leucine-rich repeat transmembrane protein FLRT2
Also known as: FLRT2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43155
- Gene
- FLRT2
- Ensembl
- ENSG00000185070
- Chromosome
- 14
- Canonical length
- 660 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a member of the fibronectin leucine rich transmembrane (FLRT) family of cell adhesion molecules, which regulate early embryonic vascular and neural development. The encoded type I transmembrane protein has an extracellular region consisting of an N-terminal leucine-rich repeat domain and a type 3 fibronectin domain, followed by a transmembrane domain and a short C-terminal cytoplasmic tail domain. It functions as both a homophilic cell adhesion molecule and a heterophilic chemorepellent through its interaction with members of the uncoordinated-5 receptor family. Proteolytic removal of the extracellular region controls the migration of neurons in the developing cortex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
660 residues, UniProt reviewed canonical sequence.
>O43155|FLRT2
1 MGLQTTKWPS HGAFFLKSWL IISLGLYSQV SKLLACPSVC RCDRNFVYCN ERSLTSVPLG
61 IPEGVTVLYL HNNQINNAGF PAELHNVQSV HTVYLYGNQL DEFPMNLPKN VRVLHLQENN
121 IQTISRAALA QLLKLEELHL DDNSISTVGV EDGAFREAIS LKLLFLSKNH LSSVPVGLPV
181 DLQELRVDEN RIAVISDMAF QNLTSLERLI VDGNLLTNKG IAEGTFSHLT KLKEFSIVRN
241 SLSHPPPDLP GTHLIRLYLQ DNQINHIPLT AFSNLRKLER LDISNNQLRM LTQGVFDNLS
301 NLKQLTARNN PWFCDCSIKW VTEWLKYIPS SLNVRGFMCQ GPEQVRGMAV RELNMNLLSC
361 PTTTPGLPLF TPAPSTASPT TQPPTLSIPN PSRSYTPPTP TTSKLPTIPD WDGRERVTPP
421 ISERIQLSIH FVNDTSIQVS WLSLFTVMAY KLTWVKMGHS LVGGIVQERI VSGEKQHLSL
481 VNLEPRSTYR ICLVPLDAFN YRAVEDTICS EATTHASYLN NGSNTASSHE QTTSHSMGSP
541 FLLAGLIGGA VIFVLVVLLS VFCWHMHKKG RYTSQKWKYN RGRRKDDYCE AGTKKDNSIL
601 EMTETSFQIV SLNNDQLLKG DFRLQPIYTP NGGINYTDCH IPNNMRYCNS SVPDLEHCHTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FLRT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- ovary: 39 nTPM
- pancreas: 23 nTPM
- cervix: 12 nTPM
- cerebral cortex: 10 nTPM
- gallbladder: 9.8 nTPM
- skeletal muscle: 9.8 nTPM
Single-cell type
- leydig cells: 1,099 nCPM
- mesothelial cells: 969 nCPM
- choroid plexus epithelial cells: 888 nCPM
- myonuclei: 853 nCPM
- retinal pigment epithelial cells: 789 nCPM
- pancreatic duct cells: 738 nCPM
Immune cell
- basophil: 0.6 nTPM
- eosinophil: 0.4 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 76 nTPM
- basal ganglia: 56 nTPM
- choroid plexus: 47 nTPM
- amygdala: 46 nTPM
- hippocampal formation: 44 nTPM
- hypothalamus: 43 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.82
- gnomAD missense Z
- 1.28
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- basement membrane organization
- fibroblast growth factor receptor signaling pathway
- heart morphogenesis
- positive regulation of synapse assembly
- regulation of neuron migration
- cell adhesion involved in heart morphogenesis
Molecular functions
- chemorepellent activity
- fibroblast growth factor receptor binding
- protein-macromolecule adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Leucine-rich repeat N-terminal domain
- Cysteine-rich flanking region, C-terminal
- Leucine-rich repeat
- Leucine-rich repeat, typical subtype
- Fibronectin type III
- Immunoglobulin-like fold
- Leucine-rich repeat domain superfamily
- Fibronectin type III superfamily
- Small Leucine-Rich Proteoglycans
- Leucine rich repeat C-terminal domain
- Leucine rich repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FLRT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FLRT2 as an antibody target. Whether an autoantibody or antibody against FLRT2 could matter depends on whether native FLRT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FLRT2 is annotated at the cell surface, where native FLRT2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FLRT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...